Involvement of PDK1, PKC and TOR signalling pathways in basal fluconazole tolerance in Cryptococcus neoformans
Open accessThe DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Summary: This study shows the importance of PDK1, TOR and PKC signalling pathways to the basal tolerance of Cryptococcus neoformans towards fluconazole, the widely used drug for treatment of cryptococcosis. Mutations in genes integral to these pathway resulted in hypersensitivity to the drug. Upon fluconazole treatment, Mpk1, the downstream target of PKC was phosphorylated and its phosphorylation required Pdk1. We show genetically that the PDK1 and TOR phosphorylation sites in Ypk1 as well as the kinase activity of Ypk1 are required for the fluconazole basal tolerance. The involvement of these pathways in fluconazole basal tolerance was associated with sphingolipid homeostasis. Deletion of PDK1, SIN1 or YPK1 but not MPK1 affected cell viability in the presence of sphingolipid biosynthesis inhibitors. Concurrently, pdk1 Δ, sin1 Δ, ypk1 Δ and mpk1 Δ exhibited altered sphingolipid content and elevated fluconazole accumulation compared with the wild type. The fluconazole hypersensitivity phenotype of these mutants, therefore, appears to be the result of malfunction of the influx/efflux systems due to modifications of membrane sphingolipid content. Interestingly, the reduced virulence of these strains in mice suggests that the cryptococcal PDK1, PKC, and likely the TOR pathways play an important role in managing stress exerted either by fluconazole or by the host environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Loewith, R., Jacinto, E., Wullschleger, S., Lorberg, A., Crespo, J. L., Bonenfant, D., Oppliger, W., Jenoe, P., & Hall, M. N. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00636-6 · Cited by 1,886 · cited 2×
“It is thought that components of TORC2 complex of S. cerevisiae, such as Avo1 (the Sin1 homologue), bound to Tor2 may hinder the binding of rapamycin/FKBP12 rendering the TORC2 complex insensitive to rapamycin (Loewith et al., 2002).”
The nuts and bolts of AGC protein kinases
Pearce, L. R., Komander, D., & Alessi, D. R. (2010) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2822 · Cited by 1,294 · cited 1×
“These putative PDK1 targets belong to the AGC (protein kinase A/protein kinase G/protein kinase C) kinase family which is highly conserved and known to play myriad roles in cellular growth, proliferation and survival in other organisms (Pearce et al., 2010).”
Cell Wall Integrity Signaling in Saccharomyces cerevisiae
Levin, D. E. (2005) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.69.2.262-291.2005 · Cited by 1,136
Cell Wall Assembly in Saccharomyces cerevisiae
Lesage, G., & Bussey, H. (2006) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00038-05 · Cited by 849
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences
Sanglard, D., & Odds, F. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00181-0 · Cited by 784
Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2006) · Science · doi:10.1126/science.1128242 · Cited by 733
Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698 · cited 1×
“This article is a U.S. Government work and is in the public domain in the USA. to drug stress (Cowen and Lindquist, 2005; Cowen et al., 2006).”
Regulatory circuitry governing fungal development, drug resistance, and disease.
Shapiro, R. S., Robbins, N., & Cowen, L. E. (2011) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00045-10 · Cited by 576
Sionov, E., Lee, H., Chang, Y. C., & Kwon-Chung, K. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000848 · Cited by 479 · cited 1×
“Further studies have shown that heteroresistance to azoles is intrinsic to all C. neoformans strains tested and heteroresistant subpopulations in each clone adapt to high concentrations of FLC by forming disomies of multiple chromosomes (Mondon et al., 1999; Sionov et al., 2009; 2010).”
Self-citationResistance Mechanisms in Clinical Isolates of Candida albicans
White, T. C., Holleman, S., Dy, F., Mirels, L. F., & Stevens, D. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1704-1713.2002 · Cited by 461
Molecular basis of resistance to azole antifungals.
Lupetti, A. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02280-3 · Cited by 449
Systematic Genetic Analysis of Virulence in the Human Fungal Pathogen Cryptococcus neoformans
Liu, O. W., Chun, C. D., Chow, E. D., Chen, C., Madhani, H. D., & Noble, S. M. (2008) · Cell · doi:10.1016/j.cell.2008.07.046 · Cited by 443
Marichal, P., Koymans, L., Willemsens, S., Bellens, D., Verhasselt, P., Luyten, W., Borgers, M., Ramaekers, F. C. S., Odds, F. C., & Vanden Bossche, H. (1999) · Microbiology · doi:10.1099/00221287-145-10-2701 · Cited by 382 · cited 1×
“…(Cowen et al., 2002; Lupetti et al., 2002; Cowen and Steinbach, 2008), mutations in ergosterol biosynthetic pathway genes (Sanglard et al., 1998; Marichal et al., 1999), amplification of genomic regions that contain ergosterol biosynthetic pathway genes and transcription factors that positively…”
LaFayette, S. L., Collins, C., Zaas, A. K., Schell, W. A., Betancourt-Quiroz, M., Gunatilaka, A. A. L., Perfect, J. R., & Cowen, L. E. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001069 · Cited by 329 · cited 3×
“Recently, PKC signalling was shown to regulate FLC resistance in C. albicans via a circuitry comprised of the Mpk1 homologue, Mkc1 (LaFayette et al., 2010).”
InfluentialAn isochromosome confers drug resistance in vivo by amplification of two genes, ERG11 and TAC1
Selmecki, A., Gerami‐Nejad, M., Paulson, C., Forche, A., & Berman, J. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06176.x · Cited by 325 · cited 1×
“…1999), amplification of genomic regions that contain ergosterol biosynthetic pathway genes and transcription factors that positively regulate a subset of efflux pump genes (Selmecki et al., 2006; 2008), as well as activation of Hsp90 that may facilitate the cell response Accepted 14 February, 2012.”
The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.
Cowen, L. E. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1835 · Cited by 311 · cited 2×
“The inhibition of these enzymes results in the blockage of ergosterol biosynthesis, accumulation of toxic sterol intermediates, and the disruption of membrane integrity (Anderson et al., 2003; Cowen, 2008; Cowen and Steinbach, 2008).”
An update on antifungal targets and mechanisms of resistance in Candidaalbicans
Akins, R. A. (2005) · Medical Mycology · doi:10.1080/13693780500138971 · Cited by 291
Stress, drugs, and evolution: the role of cellular signaling in fungal drug resistance.
Cowen, L. E., & Steinbach, W. J. (2008) · Eukaryotic Cell · doi:10.1128/ec.00041-08 · Cited by 285 · cited 3×
“The inhibition of these enzymes results in the blockage of ergosterol biosynthesis, accumulation of toxic sterol intermediates, and the disruption of membrane integrity (Anderson et al., 2003; Cowen, 2008; Cowen and Steinbach, 2008).”
Extensive In Vivo Metabolite-Protein Interactions Revealed by Large-Scale Systematic Analyses
Li, X., Gianoulis, T. A., Yip, K. Y., Gerstein, M., & Snyder, M. (2010) · Cell · doi:10.1016/j.cell.2010.09.048 · Cited by 237
Mechanism of Increased Fluconazole Resistance in Candida glabrata during Prophylaxis
Bennett, J. E., Izumikawa, K., & Marr, K. A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1773-1777.2004 · Cited by 217 · cited 1×
“…characterized in S. cerevisiae and pathogenic Candida species such as C. albicans and C. glabrata (Kontoyiannis et al., 1999; Sanglard and Odds, 2002; White et al., 2002; Bennett et al., 2004; Brun et al., 2004; Akins, 2005; Helmerhorst et al., 2006; Tsai et al., 2006; Lamping et al., 2007).”
Kraus, P. R., Fox, D. S., Cox, G. M., & Heitman, J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03508.x · Cited by 217 · cited 5×
“neoformans mutants lacking Mpk1 also exhibit attenuated virulence in the mouse model of cryptococcosis (Kraus et al., 2003).”
InfluentialChang, Y. C., Bien, C. M., Lee, H., Espenshade, P. J., & Kwon‐Chung, K. J. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05676.x · Cited by 212 · cited 1×
“The afr1D, sre1D and scp1D strains were found among the 32 FLC-s mutants and previous reports showed that deletion of each of these genes results in FLC sensitivity (Chang et al., 2007; Sionov et al., 2009).”
BackgroundSelf-citationSionov, E., Chang, Y. C., Garraffo, H. M., & Kwon-Chung, K. J. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00295-09 · Cited by 179
Self-citationMukhopadhyay, K., Prasad, T., Saini, P., Pucadyil, T. J., Chattopadhyay, A., & Prasad, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1778-1787.2004 · Cited by 163 · cited 3×
“A stable interaction between ergosterol and sphingolipid is essential to maintain the stability of sphingolipid-rich microdomains (Mukhopadhyay et al., 2004).”
Genetic Architecture of Hsp90-Dependent Drug Resistance
Cowen, L. E., Carpenter, A. E., Matangkasombut, O., Fink, G. R., & Lindquist, S. (2006) · Eukaryotic Cell · doi:10.1128/ec.00274-06 · Cited by 159 · cited 1×
“This article is a U.S. Government work and is in the public domain in the USA. to drug stress (Cowen and Lindquist, 2005; Cowen et al., 2006).”
Anderson, J. B., Sirjusingh, C., Parsons, A. B., Boone, C., Wickens, C., Cowen, L. E., & Kohn, L. M. (2003) · Genetics · doi:10.1093/genetics/163.4.1287 · Cited by 156
Mechanisms of Azole Resistance in Petite Mutants of Candida glabrata
Brun, S., Bergès, T., Poupard, P., Vauzelle-Moreau, C., Renier, G., Chabasse, D., & Bouchara, J.-P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1788-1796.2004 · Cited by 151 · cited 1×
“…characterized in S. cerevisiae and pathogenic Candida species such as C. albicans and C. glabrata (Kontoyiannis et al., 1999; Sanglard and Odds, 2002; White et al., 2002; Bennett et al., 2004; Brun et al., 2004; Akins, 2005; Helmerhorst et al., 2006; Tsai et al., 2006; Lamping et al., 2007).”
Evolution of Drug Resistance in Candida Albicans
Cowen, L. E., Anderson, J. B., & Kohn, L. M. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160907 · Cited by 151
Heteroresistance to Fluconazole and Voriconazole in Cryptococcus neoformans
Mondon, P., Petter, R., Amalfitano, G., Luzzati, R., Concia, E., Polacheck, I., & Kwon-Chung, K. J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.8.1856 · Cited by 139 · cited 4×
“An intriguing pattern of azole resistance called heteroresistance was reported in C. neoformans isolated from patients with recurrent episodes of infection (Mondon et al., 1999; Sionov et al., 2009).”
InfluentialSelf-citationAzole Drugs Are Imported By Facilitated Diffusion in Candida albicans and Other Pathogenic Fungi
Mansfield, B. E., Oltean, H. N., Oliver, B. G., Hoot, S. J., Leyde, S. E., Hedstrom, L., & White, T. C. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001126 · Cited by 111
Abe, F., Usui, K., & Hiraki, T. (2009) · Biochemistry · doi:10.1021/bi900578y · Cited by 107 · cited 2×
“cerevisiae (Abe et al., 2009).”
Cited by
Treatment strategies for cryptococcal infection: challenges, advances and future outlook
Iyer, K. R., Revie, N. M., Fu, C., Robbins, N., & Cowen, L. E. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00511-0 · Cited by 363
Cell wall integrity signalling in human pathogenic fungi: CWI signalling in pathogenic fungi
Dichtl, K., Samantaray, S., & Wagener, J. (2016) · Cellular Microbiology · doi:10.1111/cmi.12612 · Cited by 144
“The ΔCncrz1 mutant displays typical CWI phenotypes, including susceptibility to CR, CFW, SDS and caspofungin (Adler et al., 2011; Lev et al., 2012).”
BackgroundMethodCryptococcus neoformans can form titan-like cells in vitro in response to multiple signals
Trevijano-Contador, N., de Oliveira, H. C., García-Rodas, R., Rossi, S. A., Llorente, I., Zaballos, Á., Janbon, G., Ariño, J., & Zaragoza, Ó. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007007 · Cited by 124
Stress Signaling Pathways for the Pathogenicity of Cryptococcus
Bahn, Y.-S., & Jung, K.-W. (2013) · Eukaryotic Cell · doi:10.1128/ec.00218-13 · Cited by 84
Role of Amino Acid Metabolism in the Virulence of Human Pathogenic Fungi
Garbe, E., & Vylkova, S. (2019) · Current Clinical Microbiology Reports · doi:10.1007/s40588-019-00124-5 · Cited by 59
Metadata
- Authors
- Lee, H., Khanal Lamichhane, A., Garraffo, H. M., Kwon‐Chung, K. J., & Chang, Y. C.
- Venue
- Molecular Microbiology
- Publisher
- Wiley
- Published
- 2012-03-15
- Volume
- 84
- Issue
- 1
- Pages
- 130-146
- ISSN
- 0950-382X (ISSN-L)
- 1365-2958
- OpenAlex
- W1497908460
- Cited by
- 46
- References
- 31
- FWCI
- 1.94
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.